Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)
CUSIP: 45782T105
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 27,969,231
- Total 13F shares
- 992,741
- Share change
- +624,076
- Total reported value
- $10,252,248
- Price per share
- $10.30
- Number of holders
- 27
- Value change
- +$6,463,618
- Number of buys
- 19
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45782T105:
Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Financial Advocates Investment Management |
13F
|
Company |
0.84%
|
235,961
|
$1,239,000 | — | 30 Jun 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.34%
|
96,048
|
$504,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
18,802
|
$98,000 | — | 30 Jun 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
1,700
|
$9,000 | — | 30 Jun 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,355
|
$7,000 | — | 30 Jun 2020 | |
| Covington Capital Management |
13F
|
Company |
0%
|
1,000
|
$5,000 | — | 30 Jun 2020 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0%
|
1,000
|
$5,000 | — | 30 Jun 2020 | |
| TRUE Private Wealth Advisors |
13F
|
Company |
0%
|
1,000
|
$5,000 | — | 30 Jun 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
820
|
$4,000 | — | 30 Jun 2020 | |
| Private Advisor Group, LLC |
13F
|
Company |
0%
|
675
|
$4,000 | — | 30 Jun 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Jun 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
101
|
$1,000 | — | 30 Jun 2020 |
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q3 2020
As of 30 Sep 2020,
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
992,741 shares.
The largest 10 holders included
Granite Point Capital Management, L.P., VANGUARD GROUP INC, Point72 Asset Management, L.P., DEUTSCHE BANK AG\, EAM Investors, LLC, BANK OF MONTREAL /CAN/, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and Qube Research & Technologies Ltd.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
11
Q3 2020 holders
27
Holder diff
16
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.